1106 related articles for article (PubMed ID: 32374517)
1. Progressive dyspnea and diffuse ground-glass opacities after treatment for lymphoma with rituximab-containing chemotherapy: A case report.
Sun Y; Shao C; Xu K; Li J; Zhang Y; Liu P; Huang H; Feng R
Thorac Cancer; 2020 Jul; 11(7):2040-2043. PubMed ID: 32374517
[TBL] [Abstract][Full Text] [Related]
2. Diffuse large B-cell lymphoma in a patient with dermatomyositis-associated interstitial lung disease: A case report.
Li S; Sun Y; Shao C; Xu K; Huang H
Thorac Cancer; 2019 Oct; 10(10):2035-2039. PubMed ID: 31452347
[TBL] [Abstract][Full Text] [Related]
3. Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
Zhou T; Shen Q; Peng H; Chao T; Zhang L; Huang L; Yang K; Thapa S; Yu S; Jiang Y
Ann Hematol; 2018 Jan; 97(1):141-147. PubMed ID: 29086009
[TBL] [Abstract][Full Text] [Related]
4. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary intravascular large B-cell lymphoma accompanying synchronous primary pulmonary adenocarcinoma and benign interstitial lesions.
Satoh T; Arai E; Kayano H; Sakaguchi H; Takahashi N; Tsukasaki K; Yasuda M
J Clin Exp Hematop; 2019 Sep; 59(3):140-144. PubMed ID: 31391407
[TBL] [Abstract][Full Text] [Related]
6. [A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab].
Ohkubo H; Yoshida T; Ohta K; Takaku T; Katagiri T; Paku J; Kasuga I; Minemura K; Gotoh A; Serizawa H; Mukai K; Ohyashiki K
Gan To Kagaku Ryoho; 2005 Apr; 32(4):553-6. PubMed ID: 15853227
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma of the lung in a patient with nonspecific interstitial pneumonia.
Gorospe Sarasúa L; Arrieta P; Chinea-Rodríguez A; de la Puente-Bujidos C
Reumatol Clin (Engl Ed); 2019; 15(6):e151-e152. PubMed ID: 28867466
[No Abstract] [Full Text] [Related]
8. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
9. A Rare Case of Diffuse Large B Cell Lymphoma Presenting as a Cardiac Mass.
Yousif P; Kotecha A; Thakur A; Ismail HM
Am J Case Rep; 2019 Dec; 20():1821-1825. PubMed ID: 31809493
[TBL] [Abstract][Full Text] [Related]
10. A case of diffuse large B-cell lymphoma of the lung demonstrating diffuse ground-glass shadows.
Ogata-Suetsugu S; Maeyama T; Takeshita M; Hamada N; Takayama K; Inoue H; Nakanishi Y
Ann Thorac Cardiovasc Surg; 2011; 17(6):591-4. PubMed ID: 21881351
[TBL] [Abstract][Full Text] [Related]
11. [Interstitial pneumonia in patients with diffuse large B-cell lymphoma receiving RCHOP and RCDOP regimens].
Meng YN; Wang S; Shi Q; Xu PP; Cheng S; Wang L; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1015-1020. PubMed ID: 32023732
[No Abstract] [Full Text] [Related]
12. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V; Held G; Ziepert M; Witzens-Harig M; Holte H; Thurner L; Borchmann P; Viardot A; Soekler M; Keller U; Schmidt C; Truemper L; Mahlberg R; Marks R; Hoeffkes HG; Metzner B; Dierlamm J; Frickhofen N; Haenel M; Neubauer A; Kneba M; Merli F; Tucci A; de Nully Brown P; Federico M; Lengfelder E; di Rocco A; Trappe R; Rosenwald A; Berdel C; Maisenhoelder M; Shpilberg O; Amam J; Christofyllakis K; Hartmann F; Murawski N; Stilgenbauer S; Nickelsen M; Wulf G; Glass B; Schmitz N; Altmann B; Loeffler M; Pfreundschuh M; ;
Lancet; 2019 Dec; 394(10216):2271-2281. PubMed ID: 31868632
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease.
Park GH; Kim CH; Chung WK; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Acta Derm Venereol; 2010 May; 90(3):296-8. PubMed ID: 20526551
[No Abstract] [Full Text] [Related]
14. Rituximab-induced interstitial lung disease.
Wagner SA; Mehta AC; Laber DA
Am J Hematol; 2007 Oct; 82(10):916-9. PubMed ID: 17597477
[TBL] [Abstract][Full Text] [Related]
15. Primary Pulmonary Extranodal Natural Killer/T-cell Lymphoma, Nasal Type Presenting as Diffuse Ground Glass Opacities: a Case Report.
Song M; Kim JY; Choi JS; Yoon B; Kim M; Kim SJ; Kim SY
J Korean Med Sci; 2017 Oct; 32(10):1727-1730. PubMed ID: 28875622
[TBL] [Abstract][Full Text] [Related]
16. A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Malkan UY; Albayrak M; Yildiz A; Maral S; Afacan Ozturk HB; Comert P
J Oncol Pharm Pract; 2021 Jan; 27(1):250-252. PubMed ID: 32507098
[TBL] [Abstract][Full Text] [Related]
17. Lung intravascular large B-cell lymphoma with ground glass opacities on chest computed tomography: a case report.
Xiao D; Fu C; Long X; Liu W; Chen C; Zhou J; Fan S
Int J Clin Exp Pathol; 2014; 7(8):5285-90. PubMed ID: 25197411
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of concomitant metastatic prostate cancer and B-cell non-Hodgkin's lymphoma with R-EPOCH chemotherapy regimen and antiandrogen therapy.
Hanna F; Prakash A; Allan E; Khalafallah AA
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29549134
[TBL] [Abstract][Full Text] [Related]
19. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
20. Detection of the Incidence of Infections and Acute Biochemical Changes in Diffused Large B-Cell Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (CHOP) with and without Rituximab.
Ali K; Sial AA; Baig MT; Ansari SH; Adil SO; Shamsi TS
Curr Drug Saf; 2018; 13(2):102-106. PubMed ID: 29564988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]